GlassScriptPhysician profile
Chrisline Nicolas
NPI 1013441906
$2,134.21
in general payments reported to CMS, 2019-2025
16 companies · $919 in 2025
The $919 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.97 · 2022: $238 · 2023: $311 · 2024: $607 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $249.00 | 2023-2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $219.35 | 2022-2025 | Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $211.44 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $200.07 | 2023-2024 | Rexulti |
| Sun Pharmaceutical Industries INC. | $142.21 | 2025 | |
| Glaxosmithkline, LLC. | $123.05 | 2025 | Arexvy |
| Astellas Pharma US INC | $120.00 | 2025 | Veozah |
| Cipher Pharmaceuticals US LLC | $115.85 | 2025 | Spinosad, Natroba |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $106.51 | 2025 | Caplyta |
| Neurocrine Biosciences, INC. | $105.25 | 2024 | Ingrezza |
| Lilly USA, LLC | $100.00 | 2024 | Mounjaro |
| Tempus Ai, INC | $96.64 | 2024 | |
| Mylan Specialty L.P. | $90.46 | 2022 | |
| Abbvie INC. | $87.31 | 2021-2022 | |
| Inspire Medical Systems, INC. | $84.95 | 2024 | Inspire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $82.12 | 2023 | Lokelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chrisline Nicolas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.